icon-folder.gif   Conference Reports for NATAP  
 
  51th ICAAC
Chicago, IL
September 17-20, 2011
Back grey_arrow_rt.gif
 
 
 
Safety, Efficacy, and Pharmacokinetics of Ibalizumab in Treatment-Experienced HIV-1 Infected Patients: a Phase 2b Study
 
 
  Reported by Jules Levin
51st Interscience Conference on Antimicrobial Agents and Chemotherapy
September 17-20, 2011 | Chicago, IL, USA
 
H. KHANLOU1, J. GATHE2, S. SCHRADER3, W. TOWNER4, S. WEINHEIMER5, S. LEWIS5. 1 AIDS Health Care Fndn., Los Angeles, CA, 2Therapeutic Concepts, Houston, TX, 3Res. Access Network, Houston, TX, 4Kaiser Permanente, Los Angeles, CA, 5TMB USA, Irvine, CA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif